Project Umbrella Translation
ABOUT THE PLAGA TYPE 3 FIELD TEST
One week has passed since we launched the field test for the improved Plaga species, "Type 3", in this territory.
Type 3 is an improved type of Plaga we created based on the concept of "dramatically enhancing physical capabilities", unachievable with the previous Plagas. If we apply a special Plaga known as the dominant species, even the pure breed Plaga could expect greatly augmented physical abilities.
There are however a very limited number of the dominant species, and above all, it's difficult to use in some situations since it involves dramatic transformation in appearance. That's not good enough.
What we're aiming for is to create soldiers who possess superhuman physical abilities without any change in appearance. Only then will it be marketable.
Although I hear another research team's developing a similar concept product utilizing something different from the Plaga, when one considers its compatibility with humans, the Plaga's ideal to use. No matter how good a soldier we can make though, there's no point if the assimilation rate's woeful.
Therefore, we decided to develop a new Plaga species by transplanting dominant Plaga factors into the subordinate species Plaga, the so-called "ordinary" Plaga. This became "Plaga Type 3." Once we perfect Plaga Type 3, it will rechart the course of the biological weapons market in one blow.
For the time being however, that looks to be a long way off. This field test highlighted some of Type 3's problems.
Firstly, it has a low assimilation rate. Although the assimilation rate for adult males was 92%, about the same as the normal Plaga, the assimilation rate for women and children was approximately 0%.
This rendered it meaningless to use the Plaga in development for its high retention rate.
Additionally, transformations in appearance were also fatal. Changes were observed all over the body. This could be due to the dominant Plaga's factors still being deeply ingrained in it.
It's not a total failure though.
You could say to some extent we achieved our aim of dramatically enhancing physical abilities. We've made particularly remarkable progress in jumping power.
Unexpectedly, some subjects grew huge. Some grew to almost three meters. Although this could initially be attributed to the dominant Plaga's factors, you could say it's within an acceptable range.
This field test may have concluded with disappointing results, but it wasn't a total failure. Even if it did fail, we should be able to make use of it in the future.
There's hope for it yet.
One week has passed since we launched the field test for the improved Plaga species, "Type 3", in this territory.
Type 3 is an improved type of Plaga we created based on the concept of "dramatically enhancing physical capabilities", unachievable with the previous Plagas. If we apply a special Plaga known as the dominant species, even the pure breed Plaga could expect greatly augmented physical abilities.
There are however a very limited number of the dominant species, and above all, it's difficult to use in some situations since it involves dramatic transformation in appearance. That's not good enough.
What we're aiming for is to create soldiers who possess superhuman physical abilities without any change in appearance. Only then will it be marketable.
Although I hear another research team's developing a similar concept product utilizing something different from the Plaga, when one considers its compatibility with humans, the Plaga's ideal to use. No matter how good a soldier we can make though, there's no point if the assimilation rate's woeful.
Therefore, we decided to develop a new Plaga species by transplanting dominant Plaga factors into the subordinate species Plaga, the so-called "ordinary" Plaga. This became "Plaga Type 3." Once we perfect Plaga Type 3, it will rechart the course of the biological weapons market in one blow.
For the time being however, that looks to be a long way off. This field test highlighted some of Type 3's problems.
Firstly, it has a low assimilation rate. Although the assimilation rate for adult males was 92%, about the same as the normal Plaga, the assimilation rate for women and children was approximately 0%.
This rendered it meaningless to use the Plaga in development for its high retention rate.
Additionally, transformations in appearance were also fatal. Changes were observed all over the body. This could be due to the dominant Plaga's factors still being deeply ingrained in it.
It's not a total failure though.
You could say to some extent we achieved our aim of dramatically enhancing physical abilities. We've made particularly remarkable progress in jumping power.
Unexpectedly, some subjects grew huge. Some grew to almost three meters. Although this could initially be attributed to the dominant Plaga's factors, you could say it's within an acceptable range.
This field test may have concluded with disappointing results, but it wasn't a total failure. Even if it did fail, we should be able to make use of it in the future.
There's hope for it yet.
Official Japanese Transcript
プラーガ・タイプ3の実地試験について
この地で改良型プラーガ「タイプ3」の実地試験を開始して1週間が経過した。
タイプ3は、これまでのプラーガではなしえなかった「身体能力の飛躍的向上」をコンセプトに作られた改良型である。原種プラーガでも、支配種と呼ばれる特別なプラーガを使用すれば身体能力の飛躍的向上は見込める。
だが、支配種は絶対的に数が少なく、なによりも外見の劇的な変化を伴ってしまうため、状況によっては使いにくい。それではダメだ。
我々が目指すのは、外見的な変化を伴わず超人的な身体能力を有する兵士を作り出すことなのだ。それでこそ売り物になる。
別の研究チームでは、プラーガ以外を使用して似たようなコンセプト商品を開発しているらしいが、人間との親和性を考えればプラーガを使用するのが一番いい。どんなに優れた兵士を生み出すことができても定着率が悪ければ意味がない。
そこで我々は、従属種のプラーガ、いわゆる"普通の"プラーガに支配種プラーガの因子を移植することで、新しいプラーガを開発することにした。 それが「プラーガ・タイプ3」である。タイプ3が完成すれば、生物兵器市場のトレンドを一気に塗り替えてしまうだろう。
だが、それは当分先の話のようだ。今回の実地試験で、タイプ3の問題点がいくつか浮き彫りになった。
まず、定着率の低さ。成人男性への定着率は92%と通常のプラーガ並みだったが、女性と子供への定着率はほぼ0%だった。
これでは定着率の高いプラーガをベースに開発した意味がない。
また、外見的な変化も致命的だ。体中のあらゆる部分に変化が見られた。これは支配種プラーガの因子が色濃く残りすぎているせいなのかもしれない。
だが、失敗ばかりではない。
目指していた身体能力の飛躍的向上については、ある程度達成されたと言ってもよい。特に跳躍力については、目覚しい進化をとげた。
予想外だった点としては、一部の被験者が巨大化したことだろう。3メートル近くまで巨大化した者もいる。これも支配種プラーガの因子のせいだと考えられるが、まずは許容範囲内といえるだろう。
今回の実地試験は残念な結果に終わったが、完全に失敗だったわけではない。失敗だったとしても、次に活かせばよいのだ。
まだ望みはある。
この地で改良型プラーガ「タイプ3」の実地試験を開始して1週間が経過した。
タイプ3は、これまでのプラーガではなしえなかった「身体能力の飛躍的向上」をコンセプトに作られた改良型である。原種プラーガでも、支配種と呼ばれる特別なプラーガを使用すれば身体能力の飛躍的向上は見込める。
だが、支配種は絶対的に数が少なく、なによりも外見の劇的な変化を伴ってしまうため、状況によっては使いにくい。それではダメだ。
我々が目指すのは、外見的な変化を伴わず超人的な身体能力を有する兵士を作り出すことなのだ。それでこそ売り物になる。
別の研究チームでは、プラーガ以外を使用して似たようなコンセプト商品を開発しているらしいが、人間との親和性を考えればプラーガを使用するのが一番いい。どんなに優れた兵士を生み出すことができても定着率が悪ければ意味がない。
そこで我々は、従属種のプラーガ、いわゆる"普通の"プラーガに支配種プラーガの因子を移植することで、新しいプラーガを開発することにした。 それが「プラーガ・タイプ3」である。タイプ3が完成すれば、生物兵器市場のトレンドを一気に塗り替えてしまうだろう。
だが、それは当分先の話のようだ。今回の実地試験で、タイプ3の問題点がいくつか浮き彫りになった。
まず、定着率の低さ。成人男性への定着率は92%と通常のプラーガ並みだったが、女性と子供への定着率はほぼ0%だった。
これでは定着率の高いプラーガをベースに開発した意味がない。
また、外見的な変化も致命的だ。体中のあらゆる部分に変化が見られた。これは支配種プラーガの因子が色濃く残りすぎているせいなのかもしれない。
だが、失敗ばかりではない。
目指していた身体能力の飛躍的向上については、ある程度達成されたと言ってもよい。特に跳躍力については、目覚しい進化をとげた。
予想外だった点としては、一部の被験者が巨大化したことだろう。3メートル近くまで巨大化した者もいる。これも支配種プラーガの因子のせいだと考えられるが、まずは許容範囲内といえるだろう。
今回の実地試験は残念な結果に終わったが、完全に失敗だったわけではない。失敗だったとしても、次に活かせばよいのだ。
まだ望みはある。
Official English Transcript
"Due to errors or changes in localization, the following may contain inconsistencies with the official Japanese text."
TYPE 3 PLAGAS FIELD TEST
One week has passed since the initial field test of Type 3 Plagas. Type 3 was designed to display dramatically enhanced physical abilities over previous versions. The original Las Plagas had a special Plaga known as the control Plaga that would provide a host with enhanced physical abilities.
These control types were limited in number, and they always caused severe physical changes in the host, and thus it was not always expedient to use them. From a business standpoint, this was undesirable. The idea was to create super soldiers without any side effects, something consumers wanted. Teams are currently working on developing a similar product to Las Plagas for commercial use, but given the affinity Las Plagas has for human hosts, it seems advantageous to continue to develop it.
Other methods may produce superior super soldiers, but if they do not render the host completely controllable, their effectiveness would be limited.
Taking a subordinate Plaga (the base Las Plagas) and implanting a gene from the control Plaga created a new type of Plaga - the Type 3. It is believed that if Type 3 can be perfected, it will become the new standard on the bioweapons market.
But that day is still in the offing.
During a recent field test, a number of issues came to the fore. The chief problem is its ineffectual adherence rate. In adult and adolescent males the adherence rate is approximately 92 percent, the same for normal Las Plagas. For women and young children Type 3 has a 0 percent adherence rate. With these disappointing results, it is obvious that in its current state, Type 3 would not render a adequate product.
In addition, superficial mutations were invariably fatal. This is thought to be due to the dynamic influence of the control Plaga gene. The test, however, was not without some favorable results. Our goal to realize dramatic physical enhancements were somewhat realized. The jumping power of hosts has shown remarkable improvement.
Another point is one we hadn't predicted: size increase in the hosts, with some reaching a height of almost three meters. This could also be due to he gene from the control Plaga, but it is within acceptable parameters.
With this field test, we did not achieve all our initial desired results, but the test was not a complete failure. It may be possible to use the information garnered from the current tests and use them to make improvements in any future tests.
TYPE 3 PLAGAS FIELD TEST
One week has passed since the initial field test of Type 3 Plagas. Type 3 was designed to display dramatically enhanced physical abilities over previous versions. The original Las Plagas had a special Plaga known as the control Plaga that would provide a host with enhanced physical abilities.
These control types were limited in number, and they always caused severe physical changes in the host, and thus it was not always expedient to use them. From a business standpoint, this was undesirable. The idea was to create super soldiers without any side effects, something consumers wanted. Teams are currently working on developing a similar product to Las Plagas for commercial use, but given the affinity Las Plagas has for human hosts, it seems advantageous to continue to develop it.
Other methods may produce superior super soldiers, but if they do not render the host completely controllable, their effectiveness would be limited.
Taking a subordinate Plaga (the base Las Plagas) and implanting a gene from the control Plaga created a new type of Plaga - the Type 3. It is believed that if Type 3 can be perfected, it will become the new standard on the bioweapons market.
But that day is still in the offing.
During a recent field test, a number of issues came to the fore. The chief problem is its ineffectual adherence rate. In adult and adolescent males the adherence rate is approximately 92 percent, the same for normal Las Plagas. For women and young children Type 3 has a 0 percent adherence rate. With these disappointing results, it is obvious that in its current state, Type 3 would not render a adequate product.
In addition, superficial mutations were invariably fatal. This is thought to be due to the dynamic influence of the control Plaga gene. The test, however, was not without some favorable results. Our goal to realize dramatic physical enhancements were somewhat realized. The jumping power of hosts has shown remarkable improvement.
Another point is one we hadn't predicted: size increase in the hosts, with some reaching a height of almost three meters. This could also be due to he gene from the control Plaga, but it is within acceptable parameters.
With this field test, we did not achieve all our initial desired results, but the test was not a complete failure. It may be possible to use the information garnered from the current tests and use them to make improvements in any future tests.